This is the 5 th and final stock analysis on the consumer product industry series with the Johnson & Johnson dividend growth stock analysis. You can check out our past 4 stock analyses here: JNJ is another US …
George Leong: Johnson & Johnson (NYSE:JNJ), which is one of my favorite long-term stocks for income and dividend-reinvesting investors, just dropped below the $100.00-per-share level and is becoming more attractive …
Pfizer Inc. (PFE) and Johnson & Johnson (JNJ) are two of the largest health care stocks and drugmakers in the world, each with a market capitalization north of $200 billion. Both of their shares are up over the past year, …
Johnson & Johnson (NYSE: JNJ) Johnson & Johnson released its first fiscal quarter of 2015 earnings report today beating both EPS and top-line estimates. As a result, the company's stock climbed in early trading …
Johnson & Johnson stock has grown its dividend by 13% since 1970 and has compounded wealth for JNJ shareholders at a clip of nearly 14% over that same time frame. When you pay attention to any list of …
Johnson & Johnson
Johnson & Johnson (JNJ - Free Report) and Procter & Gamble (PG - Free Report) are two companies with a massive array of products to offer consumers. Johnson & Johnson has more of a health related focus across …
Procter & Gamble
After a strong surge in fiscal 2016, Johnson & Johnson’s (NYSE:JNJ) stock price extended the rally into this year, buoyed by an overall advance at the stock market and the company’s growth strategy. JNJ shares …
Johnson & Johnson
JNJ Stock a Top Dividend Name for 2016 and Beyond Johnson 38; Johnson (NYSE:JNJ) is an old stalwart, known for being one of the most reliable stocks for dividend investors. It is among an elite class of companies …
Usually, I like to look for strong stocks getting stronger. However, when some large caps give you a big pullback, it can be a timely place to look at the stock. Today, JNJ looks interesting. I plotted two lines on the SCTR. …